Showing results (51-60 of 554) with videos related to

Sort By:
Pageof 56
Annual Review of Pharmacology and Toxicology|September 18, 2023
Deciphering Drug Targets and Actions with Single-Cell and Spatial ResolutionZhengyuan Pang, Benjamin F Cravatt, Li Ye
Journal of Medicinal Chemistry|January 25, 2014
Design, synthesis, and characterization of α-ketoheterocycles that additionally target the cytosolic port Cys269 of fatty acid amide hydrolaseKaterina Otrubova, Benjamin F Cravatt, Dale L Boger
Chembiochem : a European Journal of Chemical Biology|October 6, 2005
The expanding role of mass spectrometry in metabolite profiling and characterizationElizabeth J Want, Benjamin F Cravatt, Gary Siuzdak
Biochemistry|September 18, 2018
The Spastic Paraplegia-Associated Phospholipase DDHD1 Is a Primary Brain Phosphatidylinositol LipaseJordon M Inloes, Hui Jing, Benjamin F Cravatt
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 29, 2004
Synergistic interactions between cannabinoids and environmental stress in the activation of the central amygdalaSachin Patel, Benjamin F Cravatt, Cecilia J Hillard
Future Medicinal Chemistry|July 20, 2010
Strategies for discovering and derisking covalent, irreversible enzyme inhibitorsDouglas S Johnson, Eranthie Weerapana, Benjamin F Cravatt
Angewandte Chemie (International Ed. in English)|September 9, 2005
Protein-reactive natural productsCarmen Drahl, Benjamin F Cravatt, Erik J Sorensen
Nature Chemical Biology|May 20, 2008
Disparate proteome reactivity profiles of carbon electrophilesEranthie Weerapana, Gabriel M Simon, Benjamin F Cravatt
ACS Central Science|May 31, 2021
Functionalized Scout Fragments for Site-Specific Covalent Ligand Discovery and OptimizationVincent M Crowley, Marvin Thielert, Benjamin F Cravatt
Nature Chemical Biology|January 27, 2025
Implications of frequent hitter E3 ligases in targeted protein degradation screensXiaoyu Zhang, Gabriel M Simon, Benjamin F Cravatt
Pageof 56